Cancer screening is an integral component of preventive medicine, aiming to detect malignancies at an early, more treatable stage before symptoms manifest. These screenings involve systematic examinations or tests to identify cancer or precancerous conditions in individuals who may not yet show any signs of the disease. Common cancer screening methods include mammography for breast cancer, Pap smears for cervical cancer, colonoscopies for colorectal cancer, and prostate-specific antigen (PSA) tests for prostate cancer. The goal is to catch abnormalities before they progress, allowing for timely intervention and increased chances of successful treatment. While screening recommendations may vary based on age, gender, and risk factors, the overarching objective is to facilitate early detection, which is a cornerstone of preventive medicine. Regular screenings, coupled with a comprehensive understanding of personal risk factors, empower individuals and healthcare providers to collaborate effectively in managing and mitigating the impact of cancer, aligning with the broader goal of promoting health and well-being through preventive measures.






Title : Eliminating implant failure in humans with nanomaterials: 30,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Adoption of Personalized and Precision Medicine (PPM)-guided resources in addressing national biosafety: A green light towards innovations to secure individualized, population, regional and planetary health through personalized nutrition and precision foodomics
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation